Zeinhom M, Elsayed Khalil M, Mohamed Kamel I, Kohail A, Ahmed S, ElBassiouny A
Sci Rep. 2024; 14(1):5960.
PMID: 38472241
PMC: 10933394.
DOI: 10.1038/s41598-024-56067-5.
Pang T, Zhao J, Zhang F, Piao S, Yang H, Jiao J
Evid Based Complement Alternat Med. 2020; 2020:3268047.
PMID: 32908558
PMC: 7468675.
DOI: 10.1155/2020/3268047.
Schmidt I, Walter P, Siekmann U, Plange N, Koutsonas A, Mazinani B
Graefes Arch Clin Exp Ophthalmol. 2019; 258(2):303-310.
PMID: 31863398
DOI: 10.1007/s00417-019-04568-9.
Wen L, Liu L, Tong L, Li J, Zhang K, Zhang Q
Genes Dis. 2019; 6(4):448-454.
PMID: 31832525
PMC: 6888726.
DOI: 10.1016/j.gendis.2019.01.001.
Kim R, Hur D, Kim H, Han J, Mishchenko N, Fedoreyev S
Mar Drugs. 2019; 17(9).
PMID: 31466244
PMC: 6780833.
DOI: 10.3390/md17090501.
Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue.
Lansberg M, Cereda C, Mlynash M, Mishra N, Inoue M, Kemp S
Neurology. 2015; 85(8):708-14.
PMID: 26224727
PMC: 4553034.
DOI: 10.1212/WNL.0000000000001853.
Perspective of synaptic protection after post-infarction treatment with statins.
Gutierrez-Vargas J, Cespedes-Rubio A, Cardona-Gomez G
J Transl Med. 2015; 13:118.
PMID: 25884826
PMC: 4403706.
DOI: 10.1186/s12967-015-0472-6.
Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497.
Ryu S, Kwon J, Park H, Choi I, Hwang S, Gajulapati V
Exp Neurobiol. 2015; 24(1):31-40.
PMID: 25792868
PMC: 4363332.
DOI: 10.5607/en.2015.24.1.31.
Protection after stroke: cellular effectors of neurovascular unit integrity.
Posada-Duque R, Barreto G, Cardona-Gomez G
Front Cell Neurosci. 2014; 8:231.
PMID: 25177270
PMC: 4132372.
DOI: 10.3389/fncel.2014.00231.
Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update.
Rimmele D, Thomalla G
Front Neurol. 2014; 5:35.
PMID: 24723908
PMC: 3972483.
DOI: 10.3389/fneur.2014.00035.
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke.
Chapman S, Mehndiratta P, Johansen M, McMurry T, Johnston K, Southerland A
Vasc Health Risk Manag. 2014; 10:75-87.
PMID: 24591838
PMC: 3938499.
DOI: 10.2147/VHRM.S39213.
Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside.
Ayer A, Hwang B, Appelboom G, Connolly Jr E
Transl Stroke Res. 2013; 3(4):409-17.
PMID: 24323830
DOI: 10.1007/s12975-012-0207-4.
Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit.
Barber P
Sensors (Basel). 2013; 13(6):6981-7003.
PMID: 23711462
PMC: 3715273.
DOI: 10.3390/s130606981.
Plasminogen activators and ischemic stroke: conditions for acute delivery.
Del Zoppo G
Semin Thromb Hemost. 2013; 39(4):406-25.
PMID: 23539414
PMC: 3703437.
DOI: 10.1055/s-0033-1338126.
Public and professional education on urgent therapy for acute ischemic stroke: a community-based intervention in Changsha.
Sun X, Zhang N, Wang T, Liu Y, Yang Q, Jin X
Neurol Sci. 2013; 34(12):2131-5.
PMID: 23504220
DOI: 10.1007/s10072-013-1348-2.
Clinical MRI of acute ischemic stroke.
Gonzalez R
J Magn Reson Imaging. 2012; 36(2):259-71.
PMID: 22807220
PMC: 3400122.
DOI: 10.1002/jmri.23595.
Effectiveness of mechanical endovascular thrombectomy in a model system of cerebrovascular occlusion.
Chueh J, Wakhloo A, Gounis M
AJNR Am J Neuroradiol. 2012; 33(10):1998-2003.
PMID: 22555570
PMC: 7964628.
DOI: 10.3174/ajnr.A3103.
Refining the mismatch concept in acute stroke: lessons learned from PET and MRI.
Sobesky J
J Cereb Blood Flow Metab. 2012; 32(7):1416-25.
PMID: 22510604
PMC: 3390809.
DOI: 10.1038/jcbfm.2012.54.
Predicting acute ischaemic stroke outcome using clinical and temporal thresholds.
Sablot D, Belahsen F, Vuillier F, Cassarini J, Decavel P, Tatu L
ISRN Neurol. 2012; 2011:354642.
PMID: 22462018
PMC: 3302020.
DOI: 10.5402/2011/354642.
Unwitnessed stroke: impact of different onset times on eligibility into stroke trials.
Maas M, Singhal A
J Stroke Cerebrovasc Dis. 2011; 22(3):241-3.
PMID: 21917477
PMC: 3718254.
DOI: 10.1016/j.jstrokecerebrovasdis.2011.08.004.
